UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 312

Sortiert nach

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Frontiers in immunology, 2023-03, Vol.14, p.1129459-1129459

2023

Volltextzugriff (PDF)

Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study

Frontiers in immunology, 2024-05, Vol.15, p.1394644

2024

Volltextzugriff (PDF)

Informative Censoring-A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data

Life (Basel, Switzerland), 2023-01, Vol.13 (1), p.210

2023

Volltextzugriff (PDF)

Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients

Cancer medicine (Malden, MA), 2020-11, Vol.9 (22), p.8571-8578

2020

Volltextzugriff (PDF)

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

Clinical infectious diseases, 2003-09, Vol.37 (5), p.613-627

2003

Volltextzugriff (PDF)

Clinical impact of patient population differences and genomic variation in efavirenz therapy

AIDS (London), 2008-09, Vol.22 (14), p.1709-1717

2008

Volltextzugriff (PDF)

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206

AIDS (London), 2010-07, Vol.24 (11), p.1781-1784

2010

Volltextzugriff (PDF)

Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial

The lancet HIV, 2017-07, Vol.4 (7), p.e284-e294

2017

Volltextzugriff (PDF)

Preserving the Future of Infectious Diseases: Why We Must Address the Decline in Compensation for Clinicians and Researchers

Clinical infectious diseases, 2023-11, Vol.77 (10), p.1387-1394

2023

Volltextzugriff (PDF)

Development of National and Multiagency HIV Care Quality Measures

Clinical infectious diseases, 2010-09, Vol.51 (6), p.732-738

2010

Volltextzugriff (PDF)

High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group

PloS one, 2015-07, Vol.10 (7), p.e0131001-e0131001

2015

Volltextzugriff (PDF)

The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and Diversity

The Journal of infectious diseases, 2019-08, Vol.220 (Supplement_2), p.S33-S41

2019

Volltextzugriff (PDF)

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial

Journal of clinical and translational science, 2023, Vol.7 (1), p.e40-e40, Article e40

2023

Volltextzugriff (PDF)

Undetectable Plasma HIV RNA Load Predicts Success after Hepatitis B Vaccination in HIV-Infected Persons

Clinical infectious diseases, 2005-10, Vol.41 (7), p.1045-1048

2005

Volltextzugriff (PDF)

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1

Infectious diseases and therapy, 2023-09, Vol.12 (9), p.2321-2335

2023

Volltextzugriff (PDF)

Collaborative Strategies for Antimicrobial Stewardship Programs: Navigating Financial and Regulatory Landscapes

Clinical infectious diseases, 2024-07, Vol.79 (1), p.272-273

2024

Volltextzugriff (PDF)

Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis

Antimicrobial Agents and Chemotherapy, 2005-03, Vol.49 (3), p.952-958

2005

Volltextzugriff (PDF)

Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Clinical infectious diseases, 2004-09, Vol.39 (5), p.609-629

2004

Volltextzugriff (PDF)

Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America

Clinical infectious diseases, 2014-01, Vol.58 (1), p.1-10

2014

Volltextzugriff (PDF)

Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America

Clinical infectious diseases, 2021-12, Vol.73 (11), p.e3572-e3605

2021

Volltextzugriff (PDF)

A mobile health intervention in HIV primary care: supporting patients at risk for ART non-adherence

HIV research & clinical practice, 2020-12, Vol.21 (5), p.140-150

2020

Volltextzugriff (PDF)

Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes

PloS one, 2014-11, Vol.9 (11), p.e112901-e112901

2014

Volltextzugriff (PDF)

Lipid Management in Patients Who Have HIV and Are Receiving HIV Therapy

Endocrinology and metabolism clinics of North America, 2009-03, Vol.38 (1), p.207-222

Aberg, Judith A., MD

2009

Volltextzugriff (PDF)

1 – 25 von 312

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(288)
Mit Volltextzugriff
(253)

Publikationsform

Sprache

Erscheinungsjahr

n.n

Thema

Humans
(216)
Science & Technology
(214)
Life Sciences & Biomedicine
(205)
Infectious Diseases
(140)
Female
(131)
Male
(129)
Hiv
(126)
Adult
(114)
Immunology
(111)
Human Immunodeficiency Virus
(95)
Middle Aged
(92)
Hiv Infections - Drug Therapy
(84)
Microbiology
(79)
Hiv Infections - Complications
(68)
Biological And Medical Sciences
(62)
Medical Sciences
(62)
Viral Diseases
(49)
Aids
(45)
Human Viral Diseases
(42)
Viral Diseases Of The Lymphoid Tissue And The Blood. Aids
(39)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

Menü

Weitere Dienste

Einstellungen

Therapeutic trials for long COVID-19: A call to action from the interventions taskforce of the RECOVER initiative

Higher Dose Oral Fluconazole for the Treatment of AIDS-related Cryptococcal Meningitis (HIFLAC)-report of A5225, a multicentre, phase I/II, two-stage, dose-finding, safety, tolerability and efficacy randomised, amphotericin B-controlled trial of the AIDS Clinical Trials Group

Long-term safety and impact of immune recovery in heavily treatment-experienced adults receiving fostemsavir for up to 5 years in the phase 3 BRIGHTE study

Informative Censoring-A Cause of Bias in Estimating COVID-19 Mortality Using Hospital Data

Convalescent Plasma for the Treatment of Severe COVID‐19 Infection in Cancer Patients

Guidelines for the Evaluation and Management of Dyslipidemia in Human Immunodeficiency Virus (HIV)-Infected Adults Receiving Antiretroviral Therapy: Recommendations of the HIV Medicine Association of the Infectious Disease Society of America and the Adult AIDS Clinical Trials Group

Clinical impact of patient population differences and genomic variation in efavirenz therapy

A pilot study to determine the impact on dyslipidemia of adding tenofovir to stable background antiretroviral therapy: ACTG 5206

Pitavastatin versus pravastatin in adults with HIV-1 infection and dyslipidaemia (INTREPID): 12 week and 52 week results of a phase 4, multicentre, randomised, double-blind, superiority trial

Preserving the Future of Infectious Diseases: Why We Must Address the Decline in Compensation for Clinicians and Researchers

Development of National and Multiagency HIV Care Quality Measures

High Accuracy of Common HIV-Related Oral Disease Diagnoses by Non-Oral Health Specialists in the AIDS Clinical Trial Group

The Science and Value of Diversity: Closing the Gaps in Our Understanding of Inclusion and Diversity

Effect of tesamorelin in people with HIV with and without dorsocervical fat: Post hoc analysis of phase III double-blind placebo-controlled trial

An inflammatory cytokine signature predicts COVID-19 severity and survival

Undetectable Plasma HIV RNA Load Predicts Success after Hepatitis B Vaccination in HIV-Infected Persons

Week 240 Efficacy and Safety of Fostemsavir Plus Optimized Background Therapy in Heavily Treatment-Experienced Adults with HIV-1

Collaborative Strategies for Antimicrobial Stewardship Programs: Navigating Financial and Regulatory Landscapes

Phase I Evaluation of the Safety and Pharmacokinetics of Murine-Derived Anticryptococcal Antibody 18B7 in Subjects with Treated Cryptococcal Meningitis

Primary Care Guidelines for the Management of Persons Infected with Human Immunodeficiency Virus: Recommendations of the HIV Medicine Association of the Infectious Diseases Society of America

Primary Care Guidelines for the Management of Persons Infected With HIV: 2013 Update by the HIV Medicine Association of the Infectious Diseases Society of America

Primary Care Guidance for Persons With Human Immunodeficiency Virus: 2020 Update by the HIV Medicine Association of the Infectious Diseases Society of America

A mobile health intervention in HIV primary care: supporting patients at risk for ART non-adherence

Design aspects of a case-control clinical investigation of the effect of HIV on oral and gastrointestinal soluble innate factors and microbes

Lipid Management in Patients Who Have HIV and Are Receiving HIV Therapy

Suchergebnisse filtern